ICD-9 Code 183.0
Malignant neoplasm of ovary
Not Valid for Submission
183.0 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of ovary. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
ICD-9: | 183.0 |
Short Description: | Malign neopl ovary |
Long Description: | Malignant neoplasm of ovary |
Convert 183.0 to ICD-10
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
- C56.9 - Malignant neoplasm of unspecified ovary
Code Classification
-
Neoplasms (140–239)
-
Malignant neoplasm of genitourinary organs (179-189)
- 183 Malignant neoplasm of ovary and other uterine adnexa
-
Malignant neoplasm of genitourinary organs (179-189)
Information for Medical Professionals
Index to Diseases and Injuries
References found for the code 183.0 in the Index of Diseases and Injuries:
- Adenocarcinoma M8140 3 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- papillary M8260 3
- serous M8460 3
- unspecified site 183.0
- serous M8460 3
- papillocystic M8450 3
- unspecified site 183.0
- pseudomucinous M8470 3
- unspecified site 183.0
- serous M8441 3 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- papillary
- unspecified site 183.0
- papillary
- papillary M8260 3
- Adenofibroma M9013 0
- endometrioid M8381 0 220
- malignant M8381 3 183.0
- endometrioid M8381 0 220
- Androblastoma M8630 1
- malignant M8630 3
- unspecified site
- female 183.0
- unspecified site
- malignant M8630 3
- Arrhenoblastoma M8630 1
- malignant M8630 3
- unspecified site
- female 183.0
- unspecified site
- malignant M8630 3
- Brenner s
- tumor benign M9000 0 220
- malignant M9000 3 183.0
- tumor benign M9000 0 220
- Carcinoma M8010 3 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- granulosa cell M8620 3 183.0
- Leydig cell testis M8650 3
- unspecified site 186.9
- female 183.0
- unspecified site 186.9
- papillary M8050 3
- serous M8460 3
- surface M8461 3
- unspecified site 183.0
- unspecified site 183.0
- surface M8461 3
- serous M8460 3
- papillocystic M8450 3
- unspecified site 183.0
- pseudomucinous M8470 3
- unspecified site 183.0
- serous M8441 3
- papillary M8460 3
- unspecified site 183.0
- surface papillary M8461 3
- unspecified site 183.0
- papillary M8460 3
- theca cell M8600 3 183.0
- Cyst mucus retention serous simple
- dermoid M9084 0 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- with malignant transformation M9084 3 183.0
- dermoid M9084 0 SEE ALSO
- Cystadenocarcinoma M8440 3 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- mucinous M8470 3
- papillary M8471 3
- unspecified site 183.0
- unspecified site 183.0
- papillary M8471 3
- papillary M8450 3
- mucinous M8471 3
- unspecified site 183.0
- pseudomucinous M8471 3
- unspecified site 183.0
- serous M8460 3
- unspecified site 183.0
- unspecified 183.0
- mucinous M8471 3
- pseudomucinous M8470 3
- papillary M8471 3
- unspecified site 183.0
- unspecified site 183.0
- papillary M8471 3
- serous M8441 3
- papillary M8460 3
- unspecified site 183.0
- unspecified site 183.0
- papillary M8460 3
- mucinous M8470 3
- Cystadenofibroma M9013 0
- endometrioid M8381 0 220
- malignant M8381 3 183.0
- endometrioid M8381 0 220
- Dermoid cyst M9084 0 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site benign- with malignant transformation M9084 3 183.0
- Dysgerminoma M9060 3
- unspecified site
- female 183.0
- unspecified site
- Leydig cell
- carcinoma M8650 3
- unspecified site
- female 183.0
- unspecified site
- tumor M8650 1
- malignant M8650 3
- unspecified site
- female 183.0
- unspecified site
- malignant M8650 3
- carcinoma M8650 3
- Live flesh 781.0
- nbsp
- corpus
- albicans 183.0 198.6 233.39 220 236.2 239.5
- ovary 183.0 198.6 233.39 220 236.2 239.5
- corpus
- Struma SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Goiter 240.9- ovarii M9090 0 220
- malignant M9090 3 183.0
- ovarii M9090 0 220
- Teratoma solid M9080 1 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site uncertain behavior- ovary M9080 0 220
- embryonal immature or malignant M9080 3 183.0
- ovary M9080 0 220
- Thecoma M8600 0 220
- malignant M8600 3 183.0
- Tumor M8000 1 SEE ALSO
See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site unspecified nature- brenner M9000 0 220
- malignant M9000 3 183.0
- dermoid M9084 0 see Neoplasm by site benign
- with malignant transformation M9084 3 183.0
- endodermal sinus M9071 3
- unspecified site
- female 183.0
- unspecified site
- granulosa cell M8620 1 236.2
- malignant M8620 3 183.0
- granulosa cell theca cell M8621 1 236.2
- malignant M8621 3 183.0
- Leydig cell M8650 1
- malignant M8650 3
- unspecified site
- female 183.0
- unspecified site
- malignant M8650 3
- polyvesicular vitelline M9071 3
- unspecified site
- female 183.0
- unspecified site
- yolk sac M9071 3
- unspecified site
- female 183.0
- unspecified site
- brenner M9000 0 220
Information for Patients
Ovarian Cancer
The ovaries are part of the female reproductive system. They produce a woman's eggs and female hormones. Each ovary is about the size and shape of an almond.
Cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery. But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. Then it is hard to treat. Symptoms may include:
- A heavy feeling in the pelvis
- Pain in the lower abdomen
- Bleeding from the vagina
- Weight gain or loss
- Abnormal periods
- Unexplained back pain that gets worse
- Gas, nausea, vomiting, or loss of appetite
To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery followed by chemotherapy.
NIH: National Cancer Institute
[Read More]
ICD-9 Footnotes
General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Index of Diseases and Injuries Definitions
- And - The word "and" should be interpreted to mean either "and" or "or" when it appears in a title.
- Code also note - A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- Code first - Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- Type 2 Excludes Notes - A type 2 Excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- Includes Notes - This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- Inclusion terms - List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
- NOS "Not otherwise specified" - This abbreviation is the equivalent of unspecified.
- See - The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code.
- See Also - A "see also" instruction following a main term in the Alphabetic Index instructs that there is another main term that may also be referenced that may provide additional Alphabetic Index entries that may be useful. It is not necessary to follow the "see also" note when the original main term provides the necessary code.
- 7th Characters - Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- With - The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order.